Head to head
ICL Group vs Nutrien
Side-by-side on the measures that matter, with a plain-English read. Full detail: ICL · NTR
ICL
ICL Group
4.08-1.45%
1-year price shape — -21% over the period
Quant Rating D · 18/100
vs
NTR
Nutrien
63.84-2.40%
1-year price shape — +20% over the period
Quant Rating D · 62/100
1-year performance, rebased to 100
Nutrien edges it on the scoreable measures. Nutrien has the highest Quant Rating (62); Nutrien has done best over the past year (+20%); Nutrien trades cheapest on trailing earnings.
| ICL | NTR | |
|---|---|---|
| Snapshot | ||
| Sector | Agricultural Inputs | Agricultural Inputs |
| Last price | 4.08 | 63.84 |
| Change today | -1.45% | -2.40% |
| 1-year return | -20.6% | +19.8% |
| Market cap | $5.27B | $30.27B |
| 52-week range | 4.07 – 6.84 | 51.96 – 81.36 |
| Valuation | ||
| P/E (TTM) | 16.32 | 13.94 |
| P/E percentile, own 5-yr range | 57th | 40th |
| P/B | 0.85 | 1.18 |
| Dividend yield | 5.07% | 3.44% |
| Profitability & growth | ||
| EPS (TTM) | 0.18 | 4.66 |
| Net profit (TTM) | $232.33M | $2.21B |
| Revenue (TTM) | $7.77B | $28.26B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +3.1% | +0.9% |
| Gross margin | 30.7% | 30.6% |
| Operating margin | 10.4% | 14.2% |
| Net margin | 4.0% | 7.8% |
| Free cash flow (TTM) | $281.00M | $2.09B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 74.2% | 76.9% |
| Insider activity (12mo) | 2 buy / 0 sell | 1 buy / 2 sell |
| Short interest (% of float) | 0.3% | 1.8% |
| Analyst consensus | 100% hold (3) | 62% buy / 31% hold / 8% sell (13) |
| Analyst price target | $6 (+43%) | $80 (+25%) |
| StockVane view | ||
| StockVane Quant Rating | D (18) | D (62) |
| Company | ||
| Employees | 13,007 | 25,100 |
| Founded | 1968 | 2017 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.